» Articles » PMID: 16855995

Exercise for Type 2 Diabetes Mellitus

Overview
Publisher Wiley
Date 2006 Jul 21
PMID 16855995
Citations 265
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Exercise is generally recommended for people with type 2 diabetes mellitus. However, some studies evaluate an exercise intervention including diet or behaviour modification or both, and the effects of diet and exercise are not differentiated. Some exercise studies involve low participant numbers, lacking power to show significant differences which may appear in larger trials.

Objectives: To assess the effects of exercise in type 2 diabetes mellitus.

Search Strategy: Trials were identified through the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and manual searches of bibliographies. Date of last search was March 3, 2005.

Selection Criteria: All randomised controlled trials comparing any type of well-documented aerobic, fitness or progressive resistance training exercise with no exercise in people with type 2 diabetes mellitus.

Data Collection And Analysis: Two authors independently selected trials, assessed trial quality and extracted data. Study authors were contacted for additional information. Any information on adverse effects was collected from the trials.

Main Results: Fourteen randomised controlled trials comparing exercise against no exercise in type 2 diabetes were identified involving 377 participants. Trials ranged from eight weeks to twelve months duration. Compared with the control, the exercise intervention significantly improved glycaemic control as indicated by a decrease in glycated haemoglobin levels of 0.6% (-0.6 % HbA(1c), 95% confidence interval (CI) -0.9 to -0.3; P < 0.05). This result is both statistically and clinically significant. There was no significant difference between groups in whole body mass, probably due to an increase in fat free mass (muscle) with exercise, as reported in one trial (6.3 kg, 95% CI 0.0 to 12.6). There was a reduction in visceral adipose tissue with exercise (-45.5 cm(2), 95% CI -63.8 to -27.3), and subcutaneous adipose tissue also decreased. No study reported adverse effects in the exercise group or diabetic complications. The exercise intervention significantly increased insulin response (131 AUC, 95% CI 20 to 242) (one trial), and decreased plasma triglycerides (-0.25 mmol/L, 95% CI -0.48 to -0.02). No significant difference was found between groups in quality of life (one trial), plasma cholesterol or blood pressure.

Authors' Conclusions: The meta-analysis shows that exercise significantly improves glycaemic control and reduces visceral adipose tissue and plasma triglycerides, but not plasma cholesterol, in people with type 2 diabetes, even without weight loss.

Citing Articles

Mitigating the environmental effects of healthcare: the role of the endocrinologist.

Rizan C, Rotchell J, Eng P, Robaire B, Ciocan C, Kapoor N Nat Rev Endocrinol. 2025; .

PMID: 40082727 DOI: 10.1038/s41574-025-01098-9.


Delving Into the Interaction Between Exercise and Diabetes on Methylation of the FKBP5 Gene.

Yang T, Tsai J, Hsu H, Chen Y, Liaw Y, Hsu S J Diabetes Res. 2025; 2025:1162708.

PMID: 40017583 PMC: 11865466. DOI: 10.1155/jdr/1162708.


Impact of an intervention for osteoarthritis based on exercise and education on metabolic health: a register-based study using the SOAD cohort.

Battista S, Recenti F, Kiadaliri A, Lohmander S, Jonsson T, Abbott A RMD Open. 2025; 11(1).

PMID: 40010941 PMC: 11865791. DOI: 10.1136/rmdopen-2024-005133.


Evaluation of physical activity with the International Physical Activity Questionnaire among outpatients with type 2 diabetes mellitus in Japan.

Yokoyama M, Kusuba Y, Hashizume K, Matsuura E J Rural Med. 2025; 20(1):20-27.

PMID: 39781300 PMC: 11704600. DOI: 10.2185/jrm.2024-002.


Objectively Measured Physical Activity and Sedentary Behaviour on Cardiovascular Risk and Health-Related Quality of Life in Adults: A Systematic Review.

Santos B, Monteiro D, Silva F, Flores G, Bento T, Duarte-Mendes P Healthcare (Basel). 2024; 12(18).

PMID: 39337207 PMC: 11431446. DOI: 10.3390/healthcare12181866.


References
1.
Johansen K . Efficacy of metformin in the treatment of NIDDM. Meta-analysis. Diabetes Care. 1999; 22(1):33-7. DOI: 10.2337/diacare.22.1.33. View

2.
Meltzer S, LEITER L, Daneman D, Gerstein H, Lau D, Ludwig S . 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ. 1998; 159 Suppl 8:S1-29. PMC: 1255890. View

3.
Wing R, Epstein L, Kriska A, Nowalk M, Gooding W . Exercise in a behavioural weight control programme for obese patients with Type 2 (non-insulin-dependent) diabetes. Diabetologia. 1988; 31(12):902-9. DOI: 10.1007/BF00265375. View

4.
Boule N, Haddad E, Kenny G, Wells G, Sigal R . Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001; 286(10):1218-27. DOI: 10.1001/jama.286.10.1218. View

5.
Despres J . Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Exerc Sport Sci Rev. 1997; 25:271-300. View